Roche

Experts float Roche stroke drug Activase as potential COVID-19 therapy
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Fierce Pharma
Roche
Genentech
Activase
stroke
COVID-19
Flag link:
Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands
Roche backpedals and agrees to provide a solution for Covid-19 tests in the Netherlands
Stat
Roche
COVID-19
diagnostics
Flag link:
Forge, Roche Enter Antibiotic Alliance
Forge, Roche Enter Antibiotic Alliance
Contract Pharma
Roche
Forge Therapeutics
antibiotics
drug development
FG-LpxC LUNG
lung infections
Flag link:
Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests
Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests
Fierce Pharma
Roche
Actemra
COVID-19
drug manufacturing
Flag link:
Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia
Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia
Motley Fool
Roche
Genentech
Actemra
FDA
clinical trials
COVID-19
Flag link:
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
AbbVie, Roche's Venclexta nails confirmatory combo trial in AML after flopping earlier study
Fierce Pharma
AbbVie
Roche
Venclexta
AML
clinical trials
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:
Large scale tests for coronavirus ‘unfeasible’, says Roche CEO
Large scale tests for coronavirus ‘unfeasible’, says Roche CEO
Pharmaforum
Roche
Severin Schwan
COVID-19
diagnostics
Flag link:
Roche begins phase 3 trial of Actemra in COVID-19 pneumonia
Roche begins phase 3 trial of Actemra in COVID-19 pneumonia
Pharmaforum
Roche
clinical trials
COVID-19
Actemra
Flag link:
New Coronavirus Test 10 Times Faster Is FDA Approved
New Coronavirus Test 10 Times Faster Is FDA Approved
Bloomberg
Roche
FDA
coronaviruses
COVID-19
diagnostics
Flag link:
Roche CEO Schwan sees his 2019 pay dip by 2% as his European peers get big raises
Roche CEO Schwan sees his 2019 pay dip by 2% as his European peers get big raises
Fierce Pharma
Roche
Pharma CEOs
Severin Schwan
executive pay
Flag link:
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Amgen
Allergan
biosimilars
Roche
rituximab
Flag link:
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines
China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines
Fierce Pharma
Roche
China
COVID-19
coronaviruses
Actemra
Flag link:
Roche move endorses Iteos’s Tigit widget
Roche move endorses Iteos’s Tigit widget
EP Vantage
Roche
Tigit
tiragolumab
Arcus Biosciences
iTeos Therapeutics
Flag link:
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial
Fierce Pharma
AbbVie
Roche
Venclexta
AML
blood cancer
FDA
Flag link:
U.K. Regulatory Advisor Rejects Roche Cancer Drug
U.K. Regulatory Advisor Rejects Roche Cancer Drug
Motley Fool
Roche
UK
NICE
Polivy
cancer
Flag link:
Kahr raises $18M to test CD47 drug with Roche's Tecentriq
Kahr raises $18M to test CD47 drug with Roche's Tecentriq
Fierce Biotech
Kahr Medical
anti-CD47
Roche
Tecentriq
Flag link:
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
Flag link:

Pages